SequelSEC

Outset Medical, Inc. OM

Electromedical & Electrotherapeutic Apparatus · CIK 0001484612 · Fiscal year ends 1231

Revenue
$117.80M
Fiscal year ended 2026-06-30
Operating income
-$66.04M
Fiscal year ended 2026-06-30
Free cash flow
-$38.88M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$334.70MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$18.28Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2.8×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.6×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Electromedical & Electrotherapeutic Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio6.67x90th
Gross margin39.1%19th
Long-term debt / equity0.76x80th
Revenue YoY growth5.1%25th
CapEx / revenue0.7%30th
Net margin-68.3%37th
SBC / revenue13.1%62th
Operating margin-55.8%39th
FCF margin-39.4%40th
R&D / revenue17.8%59th

Outset Medical, Inc. (OM) reported revenue of $117.80M and net income of -$74.29M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Outset Medical, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electromedical & Electrotherapeutic Apparatus.

Income

Outset Medical, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$117.80M
Cost of revenue$68.60M
Gross profit$49.20M
Operating income-$66.04M
Net income-$74.29M
Research & development$21.50M
Weighted-average diluted sharesUnavailable
Pretax income-$73.36M
Income tax expense$936.00K
Diluted EPSUnavailable
Selling, general & administrative$93.74M
General & administrative$41.88M
Selling & marketing$51.86M

Balance

Outset Medical, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$35.00M
Total assets$242.38M
Current assets$227.85M
Total liabilities$146.05M
Current liabilities$43.89M
Total equity incl. NCI$96.34M
Temporary (mezzanine) equityUnavailable
Inventory$47.32M
Accounts receivable$29.22M
GoodwillUnavailable
Long-term debt$97.65M
Accounts payable$4.46M

Cash flow

Outset Medical, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$38.32M
Capital expenditures$559.00K
Investing cash flow$33.62M
Financing cash flow$644.00K
Net change in cash-$4.05M
Stock-based compensation$15.29M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$3.31M

Derived

Outset Medical, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$38.88M
Gross margin41.8%
Operating margin-56.1%
FCF margin-33.0%
SBC / revenue13.0%
Current ratio5.19x
Revenue YoY growth-1.3%
Net margin-63.1%
R&D / revenue18.2%
CapEx / revenue0.5%
Long-term debt / equity1.01x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open OM in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-13View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.